194 related articles for article (PubMed ID: 38152849)
41. RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1.
Chen SH; Gong X; Zhang Y; Van Horn RD; Yin T; Huber L; Burke TF; Manro J; Iversen PW; Wu W; Bhagwat SV; Beckmann RP; Tiu RV; Buchanan SG; Peng SB
Oncogene; 2018 Feb; 37(6):821-832. PubMed ID: 29059158
[TBL] [Abstract][Full Text] [Related]
42. Phosphorylation of p27Kip1 regulates assembly and activation of cyclin D1-Cdk4.
Larrea MD; Liang J; Da Silva T; Hong F; Shao SH; Han K; Dumont D; Slingerland JM
Mol Cell Biol; 2008 Oct; 28(20):6462-72. PubMed ID: 18710949
[TBL] [Abstract][Full Text] [Related]
43. A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase.
Diehl JA; Sherr CJ
Mol Cell Biol; 1997 Dec; 17(12):7362-74. PubMed ID: 9372967
[TBL] [Abstract][Full Text] [Related]
44. Role of tumor necrosis factor receptor 1 (p55) in hepatocyte proliferation during acetaminophen-induced toxicity in mice.
Chiu H; Gardner CR; Dambach DM; Durham SK; Brittingham JA; Laskin JD; Laskin DL
Toxicol Appl Pharmacol; 2003 Dec; 193(2):218-27. PubMed ID: 14644624
[TBL] [Abstract][Full Text] [Related]
45. Biochemical characterizations reveal different properties between CDK4/cyclin D1 and CDK2/cyclin A.
Kim DM; Yang K; Yang BS
Exp Mol Med; 2003 Oct; 35(5):421-30. PubMed ID: 14646596
[TBL] [Abstract][Full Text] [Related]
46. Zinc finger transcription factor INSM1 interrupts cyclin D1 and CDK4 binding and induces cell cycle arrest.
Zhang T; Liu WD; Saunee NA; Breslin MB; Lan MS
J Biol Chem; 2009 Feb; 284(9):5574-81. PubMed ID: 19124461
[TBL] [Abstract][Full Text] [Related]
47. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1.
Benzeno S; Lu F; Guo M; Barbash O; Zhang F; Herman JG; Klein PS; Rustgi A; Diehl JA
Oncogene; 2006 Oct; 25(47):6291-303. PubMed ID: 16732330
[TBL] [Abstract][Full Text] [Related]
48. Modulated expression of genes encoding estrogen metabolizing enzymes by G1-phase cyclin-dependent kinases 6 and 4 in human breast cancer cells.
Jia Y; Domenico J; Swasey C; Wang M; Gelfand EW; Lucas JJ
PLoS One; 2014; 9(5):e97448. PubMed ID: 24848372
[TBL] [Abstract][Full Text] [Related]
49. Hepatocyte-specific deletion of farnesoid X receptor delays but does not inhibit liver regeneration after partial hepatectomy in mice.
Borude P; Edwards G; Walesky C; Li F; Ma X; Kong B; Guo GL; Apte U
Hepatology; 2012 Dec; 56(6):2344-52. PubMed ID: 22730081
[TBL] [Abstract][Full Text] [Related]
50. Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis.
Robitaille AM; Christen S; Shimobayashi M; Cornu M; Fava LL; Moes S; Prescianotto-Baschong C; Sauer U; Jenoe P; Hall MN
Science; 2013 Mar; 339(6125):1320-3. PubMed ID: 23429704
[TBL] [Abstract][Full Text] [Related]
51. Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice.
Tong W; Pollard JW
Mol Cell Biol; 1999 Mar; 19(3):2251-64. PubMed ID: 10022912
[TBL] [Abstract][Full Text] [Related]
52. Cyclin D2 compensates for the loss of cyclin D1 in estrogen-induced mouse uterine epithelial cell proliferation.
Chen B; Pollard JW
Mol Endocrinol; 2003 Jul; 17(7):1368-81. PubMed ID: 12649329
[TBL] [Abstract][Full Text] [Related]
53. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.
Shimura T; Kakuda S; Ochiai Y; Kuwahara Y; Takai Y; Fukumoto M
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):540-8. PubMed ID: 21398050
[TBL] [Abstract][Full Text] [Related]
54. Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation.
Tamamori-Adachi M; Ito H; Sumrejkanchanakij P; Adachi S; Hiroe M; Shimizu M; Kawauchi J; Sunamori M; Marumo F; Kitajima S; Ikeda MA
Circ Res; 2003 Jan; 92(1):e12-9. PubMed ID: 12522130
[TBL] [Abstract][Full Text] [Related]
55. Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4.
Leng X; Noble M; Adams PD; Qin J; Harper JW
Mol Cell Biol; 2002 Apr; 22(7):2242-54. PubMed ID: 11884610
[TBL] [Abstract][Full Text] [Related]
56. Roles of the ERK, JNK/AP-1/cyclin D1-CDK4 pathway in silica-induced cell cycle changes in human embryo lung fibroblast cells.
Jia X; Liu B; Shi X; Ye M; Zhang F; Liu H
Cell Biol Int; 2011 Jul; 35(7):697-704. PubMed ID: 21314641
[TBL] [Abstract][Full Text] [Related]
57. Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1, 4-Bis[2-(3,5-Dichloropyridyloxy)] benzene.
Ledda-Columbano GM; Pibiri M; Loi R; Perra A; Shinozuka H; Columbano A
Am J Pathol; 2000 Jan; 156(1):91-7. PubMed ID: 10623657
[TBL] [Abstract][Full Text] [Related]
58. Alterations of cell cycle control proteins SHP‑1/2, p16, CDK4 and cyclin D1 in radioresistant nasopharyngeal carcinoma cells.
Peng G; Cao RB; Li YH; Zou ZW; Huang J; Ding Q
Mol Med Rep; 2014 Oct; 10(4):1709-16. PubMed ID: 25109634
[TBL] [Abstract][Full Text] [Related]
59. [The effect of bombesin on cyclin D1/CDK4 of immortalized human gastric epithelial cell line].
Li J; Chen Y; Qian J; Chen Y; Sun T; Ke Y
Zhonghua Nei Ke Za Zhi; 2001 Jun; 40(6):374-6. PubMed ID: 11798599
[TBL] [Abstract][Full Text] [Related]
60. Amino acids regulate hepatocyte proliferation through modulation of cyclin D1 expression.
Nelsen CJ; Rickheim DG; Tucker MM; McKenzie TJ; Hansen LK; Pestell RG; Albrecht JH
J Biol Chem; 2003 Jul; 278(28):25853-8. PubMed ID: 12736274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
